HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 14.83
+0.04 (0.27%)
Apr 17, 2026, 2:15 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 12.36 billion as of April 16, 2026. Its market cap has increased by 117.85% in one year.
Market Cap
12.36B
Enterprise Value
9.86B
Revenue
1.23B
Ranking
n/a
PE Ratio
17.27
Stock Price
14.83
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 12.36B, an increase of 46.07%. That is a compound annual growth rate of 7.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 12.36B | 21.56% |
| Dec 31, 2025 | 10.17B | 646.35% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Leads Biolabs | 18.48B |
| Ascletis Pharma | 18.37B |
| Ascentage Pharma Group International | 18.26B |
| CStone Pharmaceuticals | 14.19B |
| Everest Medicines | 13.35B |
| CARsgen Therapeutics Holdings | 11.62B |
| Alphamab Oncology | 10.85B |
| Lepu Biopharma | 10.48B |